SLC27A5 and fatty liver disease: Knockdown of FATP2, FATP5, or CD36 leads to decrease of hepatic FFA uptake and ameliorates hepatic steatosis in mice [9,10,11], supporting the fundamental importance of FATPs and CD36 to hepatic steatosis.